To Be Discontinued Tablet Urology
Finasteride Tablet · 3 active FDA presentation rows for this drug
Brand: FINASTERIDE
FDA lists Finasteride Tablet as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Finasteride Tablet: To Be Discontinued
FDA availability text is not recorded on this row. 3 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Finasteride Tablet
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Tablet
- Presentation
- Finasteride, Tablet, 5 mg (NDC 0093-7355-56)
- Package NDC
- 0093-7355-56
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Aug 19, 2025
- Last Updated
- Aug 19, 2025
- Therapeutic Category
- Urology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug product
Full Drug Profile
finasteride
Side effects, interactions, warnings & more
Nearby, Other Finasteride Shortage Records
FDA reason on file: Discontinuation of the manufacture of the drug product. General shortage guidance lives on the tracker hub.